Location History:
- Jerusalem, IL (2014)
- Bene Ataroth, IL (2014)
- Kiriat Ono, IL (2021)
Company Filing History:
Years Active: 2014-2021
Title: Innovations and Contributions of Inventor Yuri Kogan
Introduction
Yuri Kogan is a notable inventor based in Kiriat Ono, Israel. He has made significant contributions to the field of medical technology, holding a total of 3 patents. His work focuses on developing innovative methods and systems that enhance medical treatment planning and cancer therapy.
Latest Patents
One of Kogan's latest patents is a method and system for predicting the effect of medical treatments. This computerized system is designed to plan medical treatments for individuals based on specific medical conditions. It includes a data input utility for receiving medical data and treatment endpoint data, which the data processor uses to generate output data indicative of treatment effects.
Another significant patent involves therapeutic implications of Dickkopf (Dkk) protein in cancer treatment. This method utilizes a mathematical model to simulate the effects of Dkk on cancer stem cells. It aims to determine a therapeutic regimen that can modulate cancer stem cell behavior, providing insights into cell differentiation and proliferation.
Career Highlights
Throughout his career, Yuri Kogan has worked with various organizations, including Optimata Ltd. and the Institute for Medical Biomathematics. His experience in these companies has allowed him to collaborate on groundbreaking research and development projects in the medical field.
Collaborations
Kogan has collaborated with notable professionals such as Zvia Agur and Oleg U Kirnasovsky. These partnerships have contributed to the advancement of his research and the successful implementation of his innovative ideas.
Conclusion
Yuri Kogan's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for advancements in medical treatment and cancer therapy.